Abstract:
The invention herein provides a mode of treating metabolic syndrome, which includes Type 2 diabetes mellitus and insulin resistance in human and other subjects by identifying and administering an insulin sensitizing compound which modulates GRK2 function in the insulin signaling pathway. The invention also provides polynucleotides, polypeptides, vectors, cells, tissues and organisms useful in the identification and treatment of metabolic syndrome. A number of desirable insulin sensitizing aspects are achieved by various embodiments of the present invention.
Abstract:
The invention provides an organic material-immobilizing structure employing new immobilization means, characterized in that at least a part of the surface of the substrate is comprised of one or more members containing silicon oxide, the organic material is bound to the surface of the substrate through a binding domain bound to the organic material and containing an amino acid sequence capable of binding to silicon oxide, selected from the group consisting of amino acid sequences of SEQ ID NOS: 1 and 2: Val-Ser-Pro-Met-Arg-Ser-Ala-Thr-Thr-His-Thr-Val; and Ile-Pro-Met-His-Val-His-His-Lys-His-Pro-His-Val, and derivatives thereof.
Abstract translation:本发明提供一种使用新的固定装置的有机材料固定结构,其特征在于,基底表面的至少一部分由含有氧化硅的一个或多个构件组成,有机材料通过 与有机材料结合并含有能够结合氧化硅的氨基酸序列的结合结构域,其选自SEQ ID NO:1和2的氨基酸序列:Val-Ser-Pro-Met-Arg-Ser -Ala-THR-THR-的His-THR-缬氨酸; 和Ile-Pro-Met-His-Val-His-His-Lys-His-Pro-His-Val及其衍生物。
Abstract:
There is provided a construct in which at least a part of the magnetic material is coated with polyhydroxyalkanoate (PHA), and a method for producing a construct by immobilizing a PHA synthesizing enzyme on the surface of the magnetic material thereby biosynthesizing a PHAand coatingsuch PHA on the material.
Abstract:
A structure containing polyhydroxyalkanoate and a magnetic substance includes an external phase part containing polyhydroxyalkanoate and an internal phase part contained in the external phase part, at least one of the external phase part and the internal phase part containing a magnetic substance. Accordingly, provided is a microcapsule, which can be suitably used for formation of an active ingredient of a sustained release pharmaceutical preparation or an ultrasonic contrast agent.
Abstract:
The invention provides a PHA copolymer including at least a 3-hydroxy-ω-carboxyalkanoic acid represented by a formula (19) or (32) and simultaneously at least a unit represented by a formula (2) or a formula (3) in a molecule, a precursor PHA copolymer having a corresponding vinyl group or a corresponding alkoxycarbonyl group, a biosynthesis method thereof by microorganisms, and a method of producing a desired PHA copolymer from the precursor PHA copolymer: (wherein k, m, n are integers; R 18 represents H, Na, K, R¿27? represents (A); R 1 represents a substituent on a cyclohexyl group and represents H, CN, NO 2 , a halogen atom, CH 3 , C 2 H 5 , C 3 H 7 , CF 3 , C 2 F 5 , or C 3 F 7 ; R includes a residue including a phenyl structure or a thienyl structure; these being independent for each unit).
Abstract translation:本发明提供一种PHA共聚物,其包含至少一种由式(19)或(32)表示的3-羟基-ω-羧基烷酸,同时至少由式(2)或式(3)表示的单元在 分子,具有相应的乙烯基或相应的烷氧基羰基的前体PHA共聚物,微生物的生物合成方法以及由前体PHA共聚物制备所需PHA共聚物的方法(其中k,m,n为整数; R18 代表H,Na,K,R表示(A); R1表示环己基上的取代基,代表H,CN,NO2,卤素原子,CH3,C2H5,C3H7,CF3,C2F5或C3F7; R 包括残基,包括苯基结构或噻吩基结构;它们对于每个单元是独立的)。
Abstract:
A liquid transfer apparatus comprises a liquid containing section for containing liquid, a liquid introducing section for introducing liquid into the liquid containing section and a liquid leading out section for leading out the liquid introduced into the liquid containing section. When a number of such liquid transfer apparatuses are connected together, the liquid introducing section and the liquid leading out section of such liquid transfer apparatus are arranged such that the liquid leading out section of a liquid transfer apparatus communicates with the liquid introducing section of another liquid transfer apparatus.
Abstract:
A liquid transport device capable of introducing and transporting a liquid and preventing a backward flow of the liquid in a small-sized analysis system is provided. The liquid transport device has a substrate 201, a ejection orifice 205 which is formed integrally with the substrate 201 and through which a liquid is ejected, a space portion 210 which is formed so as to communicate with the ejection orifice 205 and through which the liquid ejected from the ejection orifice flies, and a flow channel 204 which communicates with the space portion 210 and which is positioned within such a distance range that the flying liquid can reach the flow channel.
Abstract:
To provide an organic substance-immobilized structure employing a novel immobilizing technique and a manufacturing method thereof using the novel immobilizing technique, where, when an organic substance, particularly a biological substance is immobilized on the surface of a substrate, the organic substance, particularly the biological substance can be stably immobilized on the surface of the substrate through orientation of the organic substance, particularly the biological substance suitable for exerting physiological functions thereof. At least part of the substrate's surface is constructed of one or more substrates containing aluminum oxide. The immobilization of the organic substance to the surface of the substrate is carried out by binding at least part of the binding domain to the surface of the substrate through a binding domain containing a peptide having an affinity to aluminum oxide and composed of at least one or more amino acids, which is coupled with the organic substance.
Abstract:
An information acquisition method for acquiring information on a target object, that includes a step of promoting ionization of the target object using a substance for promoting ionization of the target object to cause the target object to emit, and a step of acquiring information on the mass of the flew target object using time-of-flight secondary ion mass spectrometry.
Abstract:
A fluid delivery device is provided which comprises a microchannel device for cutting out a certain amount of a sample from a micorochannel by controlling a valve opening. The fluid delivery device has a valve (301) for controlling a flow of a fluid, comprising a flow channel (304) for the fluid, and a valve (301) in the flow channel, wherein the valve operates in accordance with a pressure difference between the upstream side (304) and downstream side (303) of the valve caused by the flow of the fluid through the flow channel, allowing the fluid to flow when the pressure difference is lower than a prescribed value P0, and intercepting the fluid not to flow when the pressure difference is P0 or more.